Deutsche Bank raised the firm’s price target on HealthEquity (HQY) to $128 from $120 and keeps a Buy rating on the shares. The firm says the company’s visibility and execution continued in Q4.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- HealthEquity Inc. Earnings Call Highlights Profitable Growth
- HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target
- HealthEquity price target lowered to $110 from $125 at Barrington
- HealthEquity price target lowered to $100 from $110 at RBC Capital
- HealthEquity price target lowered to $123 from $129 at JPMorgan